PL1866338T3 - Przeciwciała przeciwko cd38 do leczenia szpiczaka mnogiego - Google Patents

Przeciwciała przeciwko cd38 do leczenia szpiczaka mnogiego

Info

Publication number
PL1866338T3
PL1866338T3 PL06722861T PL06722861T PL1866338T3 PL 1866338 T3 PL1866338 T3 PL 1866338T3 PL 06722861 T PL06722861 T PL 06722861T PL 06722861 T PL06722861 T PL 06722861T PL 1866338 T3 PL1866338 T3 PL 1866338T3
Authority
PL
Poland
Prior art keywords
treatment
antibodies against
multiple myeloma
myeloma
antibodies
Prior art date
Application number
PL06722861T
Other languages
English (en)
Polish (pl)
Inventor
Michel De Weers
Yvo Graus
Judith Oprins
Paul Parren
Jan Van De Winkel
Vugt Martine Van
Original Assignee
Genmab A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genmab A/S filed Critical Genmab A/S
Priority claimed from EP06722861.9A external-priority patent/EP1866338B1/en
Publication of PL1866338T3 publication Critical patent/PL1866338T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL06722861T 2005-03-23 2006-03-23 Przeciwciała przeciwko cd38 do leczenia szpiczaka mnogiego PL1866338T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200500429 2005-03-23
US66757905P 2005-04-01 2005-04-01
US69616305P 2005-07-01 2005-07-01
US72856105P 2005-10-20 2005-10-20
EP06722861.9A EP1866338B1 (en) 2005-03-23 2006-03-23 Antibodies against cd38 for treatment of multiple myeloma

Publications (1)

Publication Number Publication Date
PL1866338T3 true PL1866338T3 (pl) 2017-04-28

Family

ID=50644285

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06722861T PL1866338T3 (pl) 2005-03-23 2006-03-23 Przeciwciała przeciwko cd38 do leczenia szpiczaka mnogiego

Country Status (12)

Country Link
KR (1) KR20140033240A (it)
BE (1) BE2017C062I2 (it)
DK (1) DK1866338T3 (it)
ES (2) ES2644982T3 (it)
HU (2) HUE030783T2 (it)
LT (2) LT1866338T (it)
NZ (2) NZ625944A (it)
PL (1) PL1866338T3 (it)
PT (2) PT2567976T (it)
RS (1) RS55442B1 (it)
SG (1) SG10201610317VA (it)
UA (2) UA116520C2 (it)

Also Published As

Publication number Publication date
RS55442B1 (sr) 2017-04-28
LT1866338T (lt) 2017-01-25
ES2644982T3 (es) 2017-12-01
SG10201610317VA (en) 2017-02-27
PT2567976T (pt) 2017-10-19
UA116520C2 (uk) 2018-04-10
DK1866338T3 (da) 2017-01-02
HUE030783T2 (en) 2017-06-28
HUE034962T2 (en) 2018-03-28
PT1866338T (pt) 2016-12-14
UA98756C2 (ru) 2012-06-25
NZ625944A (en) 2016-01-29
ES2606762T3 (es) 2017-03-27
KR20140033240A (ko) 2014-03-17
BE2017C062I2 (it) 2025-12-03
LT2567976T (lt) 2017-12-11
NZ600059A (en) 2016-01-29

Similar Documents

Publication Publication Date Title
IL304150A (en) Antibodies against 38cd for the treatment of multiple myeloma
HRP20181565T1 (hr) Monoklonska protutijela protiv klaudina-18 za liječenje karcinoma
PL2029155T3 (pl) Ulepszony sposób leczenia szpiczaka mnogiego
IL243687A0 (en) For the treatment of multiple myeloma 1–cs antibodies against
HK40116860A (zh) 用於治疗多发性骨髓瘤的cd38抗体
PT1962913E (pt) Radioimunoconjugado para cd66 humano para o tratamento de mieloma múltiplo
HUS1700054I1 (hu) CD38-ellenes antitestek a mielóma multiplex kezelésére
SG10201610317VA (en) Antibodies against cd38 for treatment of multiple myeloma